We are live on ! Find out more
HCPC

Hamilton Capital Partners (Canada) Portfolio holdings

AUM $3.45B
1-Year Est. Return 58.23%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+58.23%
3 Year Est. Return
+142.85%
5 Year Est. Return
10 Year Est. Return
AUM
$1.16B
AUM Growth
+$222M
Cap. Flow
+$170M
Cap. Flow %
14.76%
Top 10 Hldgs %
34.19%
Holding
187
New
13
Increased
90
Reduced
53
Closed
9

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$11M
2
INTC icon
Intel
INTC
+$10.7M
3
VGIT icon
Vanguard Intermediate-Term Treasury ETF
VGIT
+$7.74M
4
TSLA icon
Tesla
TSLA
+$5.56M
5
CVS icon
CVS Health
CVS
+$3.59M

Sector Composition

Rank Sector Weight
1 Technology 26.77%
2 Healthcare 11.3%
3 Financials 11.12%
4 Materials 8.38%
5 Energy 7.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXY icon
51
Occidental Petroleum
OXY
$58.3B
$5.71M 0.49%
110,835
+20,667
+23% +$1.18M
SLB icon
52
SLB Ltd
SLB
$79.8B
$5.65M 0.49%
134,672
+11,993
+10% +$534K
COP icon
53
ConocoPhillips
COP
$152B
$5.6M 0.49%
53,219
+5,573
+12% +$612K
HAL icon
54
Halliburton
HAL
$28.7B
$5.59M 0.48%
+192,552
New +$6.07M
EOG icon
55
EOG Resources
EOG
$74.8B
$5.58M 0.48%
45,403
+1,240
+3% +$156K
DVN icon
56
Devon Energy
DVN
$50.4B
$5.48M 0.47%
+140,160
New +$6.17M
FANG icon
57
Diamondback Energy
FANG
$56.7B
$5.4M 0.47%
31,294
+1,827
+6% +$352K
SBSW icon
58
Sibanye-Stillwater
SBSW
$7.62B
$4.65M 0.4%
1,130,331
+101,087
+10% +$429K
BMY icon
59
Bristol-Myers Squibb
BMY
$130B
$4.52M 0.39%
87,456
-2,730
-3% -$128K
ABBV icon
60
AbbVie
ABBV
$441B
$4.46M 0.39%
22,576
-3,869
-15% -$722K
DHR icon
61
Danaher
DHR
$142B
$4.45M 0.38%
15,990
-2,971
-16% -$786K
TMO icon
62
Thermo Fisher Scientific
TMO
$218B
$4.44M 0.38%
7,184
-927
-11% -$549K
ISRG icon
63
Intuitive Surgical
ISRG
$139B
$4.39M 0.38%
8,945
-2,985
-25% -$1.39M
VRTX icon
64
Vertex Pharmaceuticals
VRTX
$128B
$4.39M 0.38%
9,445
-1,101
-10% -$529K
GILD icon
65
Gilead Sciences
GILD
$172B
$4.38M 0.38%
+52,283
New +$3.99M
MDT icon
66
Medtronic
MDT
$117B
$4.38M 0.38%
48,679
-6,294
-11% -$529K
BSX icon
67
Boston Scientific
BSX
$75.1B
$4.36M 0.38%
52,003
-15,018
-22% -$1.18M
ABT icon
68
Abbott
ABT
$193B
$4.35M 0.38%
38,156
-2,707
-7% -$297K
SYK icon
69
Stryker
SYK
$130B
$4.35M 0.38%
12,031
-1,189
-9% -$410K
PFE icon
70
Pfizer
PFE
$153B
$4.32M 0.37%
149,178
-22,798
-13% -$665K
MRK icon
71
Merck
MRK
$335B
$4.3M 0.37%
37,834
+829
+2% +$98.5K
CI icon
72
Cigna
CI
$74.7B
$4.26M 0.37%
12,299
-729
-6% -$251K
ELV icon
73
Elevance Health
ELV
$86.8B
$4.25M 0.37%
8,181
-1,050
-11% -$561K
REGN icon
74
Regeneron Pharmaceuticals
REGN
$82.7B
$4.21M 0.36%
4,008
-931
-19% -$1.04M
AMGN icon
75
Amgen
AMGN
$225B
$4.21M 0.36%
13,059
-1,470
-10% -$481K

Similar funds

Hamilton Capital Partners (Canada)'s Q3 2024 Portfolio in Review

As of Q3 2024, Hamilton Capital Partners (Canada) held 187 positions worth $1.16B, up 24% from $934M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Hamilton Capital Partners (Canada) deployed $170M of net new capital in Q3 2024, opening 13 new positions and adding to 90 existing holdings. Its largest new stake was Texas Instruments: 90,422 shares worth $18.7M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Tesla, an estimated $5.56M trimmed.

  • Hamilton Capital Partners (Canada)'s largest Q3 2024 buy was Texas Instruments: 90,422 shares worth $18.7M.
  • Hamilton Capital Partners (Canada) added most to Vanguard Long-Term Treasury ETF in Q3 2024, an estimated $25.9M increase.
  • Hamilton Capital Partners (Canada)'s biggest Q3 2024 reduction was Tesla, cutting an estimated $5.56M.
  • Hamilton Capital Partners (Canada) fully exited Home Depot in Q3 2024, selling an estimated $11M.
  • Hamilton Capital Partners (Canada)'s ten largest holdings make up 34% of its $1.16B portfolio in Q3 2024.
  • Hamilton Capital Partners (Canada) opened 13 new positions and closed 9 in Q3 2024.
  • Hamilton Capital Partners (Canada)'s portfolio value rose 24% quarter-over-quarter to $1.16B.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q3 2024, filed 14 Aug 2026.